- •Table of Contents
- •Copyright
- •Contributors
- •How to Use this Study Guide
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •4: Outcomes Research
- •Questions
- •Answers
- •5: Core Principles of Perioperative Care
- •Questions
- •Answers
- •Questions
- •Answers
- •7: Principles of Urologic Endoscopy
- •Questions
- •Answers
- •8: Percutaneous Approaches to the Upper Urinary Tract Collecting System
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •12: Infections of the Urinary Tract
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •15: Sexually Transmitted Diseases
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •20: Principles of Tissue Engineering
- •Questions
- •Answers
- •Questions
- •Answers
- •22: Male Reproductive Physiology
- •Questions
- •Answers
- •Questions
- •Answers
- •24: Male Infertility
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •28: Priapism
- •Questions
- •Answers
- •Questions
- •Answers
- •30: Surgery for Erectile Dysfunction
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •34: Neoplasms of the Testis
- •Questions
- •Answers
- •35: Surgery of Testicular Tumors
- •Questions
- •Answers
- •36: Laparoscopic and Robotic-Assisted Retroperitoneal Lymphadenectomy for Testicular Tumors
- •Questions
- •Answers
- •37: Tumors of the Penis
- •Questions
- •Answers
- •38: Tumors of the Urethra
- •Questions
- •Answers
- •39: Inguinal Node Dissection
- •Questions
- •Answers
- •40: Surgery of the Penis and Urethra
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •47: Renal Transplantation
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •50: Upper Urinary Tract Trauma
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •53: Strategies for Nonmedical Management of Upper Urinary Tract Calculi
- •Questions
- •Answers
- •54: Surgical Management for Upper Urinary Tract Calculi
- •Questions
- •Answers
- •55: Lower Urinary Tract Calculi
- •Questions
- •Answers
- •56: Benign Renal Tumors
- •Questions
- •Answers
- •57: Malignant Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •59: Retroperitoneal Tumors
- •Questions
- •Answers
- •60: Open Surgery of the Kidney
- •Questions
- •Answers
- •Questions
- •Answers
- •62: Nonsurgical Focal Therapy for Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •66: Surgery of the Adrenal Glands
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •71: Evaluation and Management of Women with Urinary Incontinence and Pelvic Prolapse
- •Questions
- •Answers
- •72: Evaluation and Management of Men with Urinary Incontinence
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •76: Overactive Bladder
- •Questions
- •Answers
- •77: Underactive Detrusor
- •Questions
- •Answers
- •78: Nocturia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •82: Retropubic Suspension Surgery for Incontinence in Women
- •Questions
- •Answers
- •83: Vaginal and Abdominal Reconstructive Surgery for Pelvic Organ Prolapse
- •Questions
- •Answers
- •Questions
- •Answers
- •85: Complications Related to the Use of Mesh and Their Repair
- •Questions
- •Answers
- •86: Injection Therapy for Urinary Incontinence
- •Questions
- •Answers
- •87: Additional Therapies for Storage and Emptying Failure
- •Questions
- •Answers
- •88: Aging and Geriatric Urology
- •Questions
- •Answers
- •89: Urinary Tract Fistulae
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •92: Tumors of the Bladder
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •95: Transurethral and Open Surgery for Bladder Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •99: Orthotopic Urinary Diversion
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Answers
- •Questions
- •Answers
- •108: Prostate Cancer Tumor Markers
- •Questions
- •Answers
- •Questions
- •110: Pathology of Prostatic Neoplasia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •114: Open Radical Prostatectomy
- •Questions
- •Answers
- •Questions
- •Answers
- •116: Radiation Therapy for Prostate Cancer
- •Questions
- •Answers
- •117: Focal Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •119: Management of Biomedical Recurrence Following Definitive Therapy for Prostate Cancer
- •Questions
- •Answers
- •120: Hormone Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •124: Perinatal Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •126: Pediatric Urogenital Imaging
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •133: Surgery of the Ureter in Children
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •137: Vesicoureteral Reflux
- •Questions
- •Answers
- •138: Bladder Anomalies in Children
- •Questions
- •Answers
- •139: Exstrophy-Epispadias Complex
- •Questions
- •Answers
- •140: Prune-Belly Syndrome
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •144: Management of Defecation Disorders
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •147: Hypospadias
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •152: Adolescent and Transitional Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •154: Pediatric Genitourinary Trauma
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
31
Diagnosis and Management of
Peyronie Disease
Laurence A. Levine; Stephen Larsen
Questions
1.Peyronie disease (PD):
a.is a wound healing disorder.
b.is an autoimmune disease.
c.frequently spontaneously recovers (30% to 50% of the time).
d.may degenerate into cancer.
e.is associated with Dupuytren contracture in 40% of men.
2.The fibrous plaques in PD originate in:
a.Buck fascia.
b.the substance of the corpora cavernosa.
c.the substance of the corpus spongiosum.
d.the tunica albuginea surrounding the corpora cavernosa.
e.the tunica albuginea surrounding the corpus spongiosum.
3.Based on recent natural history studies on PD, a 54-year-old man with a 60degree dorsal curve 18 months after onset suggests:
a.40% chance of spontaneous improvement of deformity.
b.70% chance of getting worse.
c.10% chance of getting worse.
d.10% or less chance of spontaneous improvement of deformity.
e.80% chance of staying the same.
4.What is the prevalence of PD following radical prostatectomy?
a.4%
b.1% to 3%
c.11% to 16%
d.> 20%
e.0%
5.Plaque calcification:
a.can be reliably identified on physical examination.
b.can be found in 50% to 60% of men with PD.
c.is not an indication of stable, mature disease.
d.is associated with successful intralesional injection therapy.
e.is a predictive factor for the need for surgical treatment.
6.Psychological distress in men with PD:
a.is infrequent.
b.is typically resolved by successful surgery.
c.is frequently associated with penile shortening.
d.correlates with degree of erect curvature.
e.has no association with relationship issues with the patient's partner.
7.All of the following statements regarding the physical examination of a man presenting with PD are true EXCEPT that the examination:
a.should include measurement of plaque size with calipers.
b.should include direct assessment of curvature following injection of vasoactive agent.
c.should include measurement of stretched penile length.
d.can be supported with a picture of the erect penis by a smartphone.
e.should include assessment of the patient's palms.
8.Penile duplex ultrasound is a valuable test for men with PD. Yet it does not provide information about:
a.penile deformity when erect.
b.erectile response to vasoactive penile injection.
c.penile vascular flow parameters.
d.penile sensory integrity.
e.plaque calcification.
9.Pentoxifylline and the phosphodiesterase-5 (PDE5) inhibitors have been shown in an animal model of PD to reduce scarring by what proposed mechanism?
a.Improved penile blood flow
b.Anti-inflammatory
c.Elevated local levels of nitric oxide (NO)
d.Anti-transforming growth factor-β (TGF-β)
e.Mechanotransduction
. Penile injection therapy (i.e., prostaglandin E1, TriMix-gel, etc.) for ED is not
directly responsible for:
a.cavernosal fibrosis.
b.Peyronie disease.
c.penile pain.
d.priapism.
e.high success rate.
.A 35-year-old man with Peyronie disease is able to achieve an erection adequate for intercourse with minimal discomfort and reported dorsal erect penile curvature of 20 degrees. The initial treatment should be:
a.reassurance.
b.oral vitamin E.
c.intralesional steroids.
d.oral tamoxifen.
e.intralesional collagenase.
.A 66-year-old man presents with a 2-year history of PD and a 55-degree dorsal curvature. He also notes that his average-grade erection with sexual stimulation at home is a grade 5/10, which would not be adequate for intromission even if the penis were straight. Duplex ultrasound analysis demonstrates arterial insufficiency and an inadequate erectile response to
90 mg of intracorporal papaverine. The most appropriate treatment option for this patient who wants to resume sexual activity would be:
a.oral vitamin E or potassium para-aminobenzoate (Potaba).
b.vacuum constriction device.
c.penile prosthesis with penile straightening.
d.intralesional verapamil injections.
e.oral colchicine.
.Tunica plication is preferred for mild to moderate curvature correction because of:
a.less shortening compared with grafting.
b.better sensory protection.
c.diminished risk of postoperative ED.
d.greater potential for loss of erect length.
.Postoperative rehabilitation is designed to aid in postoperative healing and outcomes in the following ways, EXCEPT:
a.to prevent shortening and possibly recover some lost length.
b.to encourage straight healing.
c.to enhance cicatrix contracture.
d.to preserve vascular integrity.
e.to encourage partner participation.
.All of following are true regarding penile traction therapy after surgical penile straightening, EXCEPT:
a.increases or preserves postoperative length.
b.encourages tissue remodeling.
c.should be used for 3 or more hours/day for optimum results.
d.increases the risk of sensory change.
e.results appear dose-related.
.What is the most common adverse event occurring after manual modeling during placement of a penile prosthesis in a man with PD?
a.Tunica tear proximal
b.Urethral injury
c.Sensory deficit
d.Recurrent curvature
e.Distal urethral perforation
.Indications to perform a plaque incision or partial excision and grafting include all of the following, EXCEPT:
a.severe curvature in excess of 70 degrees.
b.indentation resulting in an unstable penis or hinge effect.
c.a short penis (< 9 cm) with severe curve and poor rigidity.
d.a short penis with severe curvature and excellent rigidity.
e.extensive plaque calcification associated with severe deformity.
.The primary postoperative side effect occurring following a grafting procedure for PD is:
a.erectile dysfunction.
b.incomplete correction of hinge effect.
c.shortening.
d.diminished sexual sensation.
e.infection.
.The primary reason to consider a grafting procedure to correct penile deformity in a man with PD is:
a.a severe ventral curve.
b.suboptimal rigidity even with PDE5 inhibitors.
c.severe curve greater than 60 to 70 degrees with or without hinge effect.
d.a 90-degree lateral curve presenting 6 months after onset.
e.to gain length as a result of surgery.